PSA Response Rates Far Exceeded Expectations in Treating Asymptomatic, Androgen-Resistant Prostate Cancer With AbirateroneSeptember 22, 2015Oncology
A Rare Case of Seronegative Cat Scratch Disease Masquerading as Relapsed Hodgkin LymphomaSeptember 22, 2015Hematologic Malignancies
Prevalence of Prostate-Specific Antigen Testing Informed Consent Among Veteran Males Aged 55 to 69 YearsSeptember 22, 2015Oncology
Veterans With Castration-Resistant Prostate Cancer: Characteristics and TreatmentSeptember 22, 2015Oncology
Audiologic Rehabilitative Service Utilization Among Veterans Exposed to Cisplatin: A Retrospective ReviewSeptember 22, 2015Oncology
Impact of Treatment Sequencing on Outcomes and Costs in Relapsed Low-Grade or Follicular B-Cell Non-Hodgkin LymphomaSeptember 22, 2015Hematologic Malignancies
A Veterans Health Administration Disease Management Program: The Hudson Valley ModelSeptember 21, 2015Oncology
Simultaneous Integrated Boost in Lieu of Vaginal Brachytherapy Boost in Endometrial CancerSeptember 21, 2015Oncology
Targeting Argininosuccinate Synthetase Negative Tumors, Using a Combination of Arginine Degrading Enzyme and CisplatinSeptember 21, 2015Oncology
Brentuximab Vedotin in a Patient With Aggressive Systemic Mastocytosis and Pure Red Cell AplasiaSeptember 21, 2015Hematologic Malignancies
